Journal Articles

 

Bradford Hill A. Statistical Evidence and inference. In: Principles of Medical Statistics. 9th Edition ed. London: The Lancet; 1971. p.312-320.

 

 

World Health Organization. International Health Regulations (2005): Areas of work for implementation. June 2007; pages 5–12. http://www.who.int/ihr/finalversion9Nov07.pdf

 

 

Schlipkoter U, Flahault A. Communicable diseases: achievements and challenges for public health. Public Health Reviews 2010;32:90-119. http://www.publichealthreviews.eu/show/f/33

 

 

Gensini GF, Yacoub MH, Conti AA. The concept of quarantine in history: from plague to SARS. J Infect; 2004:49:257-261

 

 

Osterholm M, Preparing for the Next Pandemic New England Journal of Medicine 2005, 352;18:

1839-42.

 

 

Plotkin SA. Vaccines, vaccination, and vaccinology. Journal of Infectious Diseases. 2003, 187(9):1349-59.

 

 

Coker RJ et al. Health in South East Asia 3. Emerging infectious diseases in southeast Asia: regional challenges to control. Lancet. 2011;377: 599-609.

 

 

Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004;430:242-249.

 

 

Assiri et al. Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus. N Engl J Med 2013; doi: 10.1056/NEJMoa1306742.

 

 

Breban et al. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013; doi:10.1016/S0140-6736(13)61492-0 ME.

 

 

World Health Organisation. A framework for global outbreak alert and response. WHO/CDC/CSR/2000.2. WHO: Geneva, 2001. http://www.who.int/csr/resources/publications/surveillance/WHO_CDS_CSR_2000_2/

 

 

Raviglione M et al. Scaling up of interventions to achieve global tuberculosis control: progress, new developments and update. Lancet 2012: 379: 1902-13.

 

 

Marais B et al. Tuberculosis co-morbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 2013; 13: 436-48.

 

 

Kim KJ et.al. Redefining global health-care delivery. Lancet 2013; doi: 10.1016/S0140-6736(13)61047-8.

 

 

Lawn SD et.al. Advances in diagnostic assays for tuberculosis: The Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13: 349-61.

 

 

Keshavjee S et.al. Tuberculosis, Drug Resistance, and the History of Modern Medicine; N Engl J Med 2012; 367: 931-6.

 

 

Marais B et al. Tuberculosis 8. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010; 375:2179-91.

 

 

Halstead S. Dengue. Lancet.  2007;370:1644–1652.

 

 

Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comparative Immunology Microbiology & Infectious Diseases. 2004;27: 319–330

 

 

Shey Wiysonge C, Nomo E, Mawo J, Ofal J, Mimbouga J, Ticha J and Ndumbe P. Yellow fever control in Cameroon: where are we now and where are we going? BMC Medicine. 2008;6:3.

 

 

Morrison AC, Zielinski-Gutierrez E, Scott TW, Rosenberg R. Defining challenges and proposing solutions for control of the virus vector Aedes aegypti. PLoS Med. 2008;5(3):e68.

 

 

Kittayapong P, Chansang U, Chansang C and Bhumiratana A. Community participation and appropriate technologies for dengue vector control at transmission foci in Thailand. Journal of the American Mosquito Control Association.  2006;22(3):538-546.

 

 

Britton W and Lockwood D. Leprosy. Lancet. 2004;363L:1209-19

 

 

WHO. Global strategy for Further Reducing the Leprosy Burden and Sustaining Leprosy Control Activities.  Plan period: 2006 – 2010).

2005.  WHO Geneva. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=19732&Itemid= 

 

Weiand D. Assessing and improving adherence with multidrug therapy. Lepr Rev. 2012;83(3):282-91.

 

 

Liaw and Chu. Hepatitis B virus infection. Lancet 2009;373(9663):582–92.

 

 

Hajarizadeh et al. Epidemiology and natural history of HCV infection. Nature Rev Gastroenterol and Hepatol 2013; doi:10.1038/nrgastro.2013.107.

 

 

Tallo VL, Carabin H, Alday PP, Balolong E, Olveda RM, McGarvey ST. Is mass treatment the appropriate schistosomiasis elimination strategy? Bull World Health Organ 2008; 86: 765-71.

 

 

King CH. Toward the Elimination of Schistosomiasis. The New England Journal of Medicine 2009; 360 (2):106-109.

 

 

Mitja O, Paru R, Hays R, Griffin L, Laban N, Samson M, Bassat Q. The impact of flariasis control program on Lihir island, Papua New Guinea. PLos Negl Trop Dis 2011; 5(8):e1286.

 

 

Padmasiri EA, Montresor A, Biswas G and deSilva NR. Controlling lymphatic filariasis and soil transmitted healminthiasis together in South Asia: opportunities and challenges. Royal Society of Tropical Medicine and Hygiene 2006; 100:807-810.

 

 

Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, Zhang Y etal. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008. Parasitology 2009; 136 (13): 1719-1730.

 

 

Klempner MS, Shapiro DS. Crossing the species barrier – one small step to man, one giant leap to mankind. The New England Journal of Medicine. 2004; 350 (12) :1171-1172

 

 

Lembo T et al. The Feasibility of Canine Rabies Elimination in Africa: Dispelling Doubts with Data. PLoS Neglected Tropical Diseases. 2010;4(2):e626.

 

 

Global aspects of emerging and potential zoonoses: a WHO perspective.

Conference report. Emerging Infectious Diseases ;1997;3:223-8

 

 

World Health Organization. 2006. The control of Neglected Zoonotic Diseases. http://whqlibdoc.who.int/publications/2006/9789241594301_eng.pdf

 

 

Wolfe ND et al. Origins of major human infectious diseases. Nature. 2007; 447: 279-283.

 

 

Craun GF, Frost FJ, Calderon RL et al. Improving waterborne disease outbreak investigations.

International Journal of Environmental Health Research 2001; 11:229- 243.

 

 

Fedson D. Meeting the challenge of influenza pandemic preparedness in developing countries. Emerging Infectious Diseases. 2009;15 (3);365-371.

 

 

Van Kerkhove MD, Mumford E, Mounts AW, Bresee J, Ly S et al. Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review. PloS one, EISSN 1932-6203, 2011, Volume 6, Issue 1, p. e14582

 

 

Cohen D, Carter P. WHO and the pandemic flu “conspiracies”. BMJ 2010; 340: 1274-1279.

 

 

Dawood FS et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modeling study. Lancet Infectious Diseases; http://dx.doi.org/10.1016/S1473-3099(12)70152-4.

 

 

Chang MS, EM Christophel, D Gopinath and RM Abdur. Challenges and future perspective for dengue vector control in the Western Pacific Region. WPSAR 2011; 2(2): 1-8. http://www.wpro.who.int/wpsar/volumes/02/2/2011_RA_Chang/en/

 

 

Macıasa AE and S Ponce-de-Leon. Infection Control: Old Problems and New Challenges. Archives of Medical Research 2005; 36: 637–645.

 

 

Shiffman J. Donor funding priorities for communicable disease control in the developing world. Health Policy and Planning 2006; 21(6):411-420.

 

 

Ly S, Buchy P, Heng NY, Ong S, Chhor N, et al. Rabies Situation in Cambodia. PLoS Negl Trop Dis 2009; 3(9): e511. Free access available at: http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0000511

 

 

Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid Fever. New England Journal of Medicine. 2002; 347:1770-1782.

 

 

Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. The Lancet. 2005; 366(9487):749-762.

 

 

Sugerman DT. Antibiotic Resistance. Journal of the American Medical Association, 2013, 310(20):2212.

 

 

Bush K, Courvalin P, Dantas, G, Davies J, Eisenstein B et al. Tackling antibiotic resistance

Nature Reviews. Microbiology 2011, 9(12): 894-6.

 

 

Predicting antibiotic resistance. Martínez JL, Baquero F, Andersson DI. Nature Reviews. Microbiology, 2007; 5(12):958-65.